The Latest
-
Why I would buy CBA and these ASX dividend shares
-
5 things to watch on the ASX 200 on Tuesday
-
Novavax starts Phase 1 clinical trial of coronavirus vaccine candidate
-
A Lot of Optimism Embedded In Risk Asset Pricing, Saxo Capital Markets Says